Portola Pharma Stock Price, News & Analysis
PTLA
NASDAQ
Company Description
Portola Pharma (NASDAQ: PTLA) is a publicly traded pharmaceuticals: other company in the Health Technology sector.
PTLA stock has declined 32.5% over the past year.
This page provides a comprehensive overview of PTLA stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
$—
0.00%
0.00
Last updated:
-32.47%
Performance 1 year
$0.0
78.5M
Portola Pharma (PTLA) stock. Over the past 12 months, the stock has lost 32.5%.
Latest News
Portola Pharma has 1 recent news article. View all PTLA news →
SEC Filings
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Days to Cover History
Last 12 Months
PTLA Company Profile & Sector Positioning
Portola Pharma (PTLA) operates in the Pharmaceuticals: Other industry within the broader Health Technology sector and is listed on the NASDAQ.